Evidence map›Paper›PMID 27307223›Full record

ArticleNeurogenetics2016

A mutation in the THG1L gene in a family with cerebellar ataxia and developmental delay.

Simon Edvardson, Yael Elbaz-Alon, Chaim Jalas, Ashanti Matlock, Krishna Patel, Katherine Labbé, Avraham Shaag, Jane E Jackman, Orly Elpeleg

Abstract read
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The life and times of a tRNA.RNA (New York, N.Y.) · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Genomic and phenotypic delineation of congenital microcephaly.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  14. Two separate functions of NME3 critical for cell survival underlie a neurodegenerative disorder.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Simon EdvardsonMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yael Elbaz-AlonDepartment of Molecular and Cellular Biology, University of California, Davis, Davis, CA, 95616, USA.
Chaim JalasBonei Olam, Center for Rare Jewish Genetic Disorders, Brooklyn, NY, USA.
Ashanti MatlockDepartment of Chemistry and Biochemistry, Ohio State Biochemistry Program and Center for RNA Biology, The Ohio State University, Columbus, OH, USA.
Krishna PatelDepartment of Chemistry and Biochemistry, Ohio State Biochemistry Program and Center for RNA Biology, The Ohio State University, Columbus, OH, USA.
Katherine LabbéDepartment of Molecular and Cellular Biology, University of California, Davis, Davis, CA, 95616, USA.
Avraham ShaagMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Jane E JackmanDepartment of Chemistry and Biochemistry, Ohio State Biochemistry Program and Center for RNA Biology, The Ohio State University, Columbus, OH, USA. jackman.14@osu.edu.
Orly ElpelegMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Elpeleg@hadassah.org.il.
Hadassah Medical Center · ILThe Ohio State University · USUniversity of California, Davis · USKingsbrook Jewish Medical Center · US

Funding

Molecular Mechanism and Biological Function of 3'-5' PolymerasesR01GM087543 · NIGMS · OHIO STATE UNIVERSITY · PI JACKMAN, JANE ELIZABETH · 2010 to 2019
$2.7M
CIHRNIGMS NIH HHS R01 GM087543
6 · The paper itself

Abstract

Autosomal-recessive cerebellar atrophy is usually associated with inactivating mutations and early-onset presentation. The underlying molecular diagnosis suggests the involvement of neuronal survival pathways, but many mechanisms are still lacking and most patients elude genetic diagnosis. Using whole exome sequencing, we identified homozygous p.Val55Ala in the THG1L (tRNA-histidine guanylyltransferase 1 like) gene in three siblings who presented with cerebellar signs, developmental delay, dysarthria, and pyramidal signs and had cerebellar atrophy on brain MRI. THG1L protein was previously reported to participate in mitochondrial fusion via its interaction with MFN2. Abnormal mitochondrial fragmentation, including mitochondria accumulation around the nuclei and confinement of the mitochondrial network to the nuclear vicinity, was observed when patient fibroblasts were cultured in galactose containing medium. Culturing cells in galactose containing media promotes cellular respiration by oxidative phosphorylation and the action of the electron transport chain thus stimulating mitochondrial activity. The growth defect of the yeast thg1Δ strain was rescued by the expression of either yeast Thg1 or human THG1L; however, clear growth defect was observed following the expression of the human p.Val55Ala THG1L or the corresponding yeast mutant. A defect in the protein tRNA

Indexed as

MutationBrainCerebellar AtaxiaDevelopmental DisabilitiesFemaleHomozygoteHumansMagnetic Resonance ImagingMaleMitochondrial DynamicsPedigreeProteinsSiblingsProteinsTHG1L protein, humanCerebellar atrophyMitochondrial disordersMitochondrial fusion

Identifiers

PMID27307223
OpenAlexW2441162696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.